New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

In a week in which two biotechs went public and a third opted for a billion-dollar takeout instead of an IPO, five companies filed on Friday to list on NASDAQ in IPOs that could raise a total of $611.3 million. The group includes BridgeBio, Dermavant, Prevail, Atreca and Akero.

BridgeBio Pharma LLC (Palo Alto, Calif.) proposed to raise up to $225 million in an IPO underwritten by J.P. Morgan, Goldman Sachs, Jefferies, SVP Leerink, KKR, Piper Jaffray,

Read the full 773 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE